Got to agree that Neuren haven't done a sterling job on communications and promotion. The Phase 2b results would have been a great media exposure opportunity. Plenty more they could have done to promote their story.
Better that they deliver on the technical side of the program than promote a drug that falls short.
Got to agree that Neuren haven't done a sterling job on...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.85 |
Change
0.235(1.73%) |
Mkt cap ! $1.784B | |||
| Open | High | Low | Value | Volume |
| $13.60 | $14.00 | $13.51 | $2.929M | 211.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 116 | $13.84 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.85 | 1938 | 13 |
View Market Depth
| Last trade - 15.43pm 13/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |